A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function
Akemi Takata1, Motoyuki Otsuka, Takeshi Yoshikawa
1Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Abstract:
Hepatocellular carcinoma is the third leading cause of cancer mortality worldwide, but the molecular mechanisms in tumorigenesis remain largely unknown. Previously, a DEAD-box protein DDX20, a component of microRNA-containing ribonucleoprotein complexes, was identified as a liver tumor suppressor candidate in an oncogenomics-based in vivo RNAi screen. However, the molecular mechanisms were unknown. Here, we show that deficiency of DDX20 results in the enhancement of NF-κB activity, a crucial intracellular signaling pathway closely linked with hepatocarcinogenesis. While DDX20 normally suppresses NF-κB activity by regulating NF-κB-suppressing miRNA-140 function, this suppressive effect was lost in DDX20-deficient cells. The impairment of miRNA function due to DDX20 deficiency appears to be miRNA species-specific at the point of loading miRNAs into the RNA-induced silencing complex. These results indicate that DDX20 deficiency enhances NF-κB activity by impairing the NF-κB-suppressive action of microRNAs, and suggest that dysregulation of the microRNA machinery components may also be involved in pathogenesis in various human diseases.
Insights
Hepatocellular carcinoma research reveals DEAD-box protein DDX20 normally suppresses NF-κB activity. DDX20 deficiency enhances liver cancer risk by impairing microRNA function, highlighting microRNA machinery
Area of Science:
- Hepatocellular carcinoma research
- Molecular mechanisms of tumorigenesis
- MicroRNA regulation
Background:
- Hepatocellular carcinoma (HCC) is a major global cancer mortality cause.
- Molecular drivers of HCC tumorigenesis are not fully understood.
- DEAD-box protein DDX20 was previously identified as a potential liver tumor suppressor.
Purpose of the Study:
- To elucidate the molecular mechanisms by which DDX20 influences hepatocarcinogenesis.
- To investigate the role of DDX20 in regulating NF-κB signaling pathway.
- To understand how DDX20 deficiency impacts microRNA function in liver cancer.
Main Methods:
- Investigated the effect of DDX20 deficiency on NF-κB activity in liver cells.
- Examined the interaction between DDX20 and microRNA-140.
- Analyzed the impact of DDX20 deficiency on microRNA loading into the RNA-induced silencing complex (RISC).
Main Results:
- DDX20 deficiency leads to enhanced NF-κB activity, a key pathway in liver cancer.
- DDX20 normally suppresses NF-κB activity by regulating microRNA-140.
- DDX20 deficiency impairs microRNA function in a species-specific manner, affecting miRNA loading into RISC.
Conclusions:
- DDX20 deficiency promotes hepatocarcinogenesis by enhancing NF-κB activity through impaired microRNA suppression.
- Dysregulation of microRNA machinery components, like DDX20, may contribute to various human diseases.
- DDX20's role as a tumor suppressor is linked to its function in microRNA pathway regulation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MicroRNAs
MicroRNAs
MicroRNAs
Co-activators and Co-repressors


